Andres Duarte-Rojo is a clinical investigator and a professor at Northwestern, Feinberg School of Medicine. He is the current Section Chief of Hepatology, and Medical Director for the Liver Transplant Program at Northwestern's Comprehensive Transplant Center. Following completion of internal medicine and gastroenterology programs, he trained in clinical hepatology (U. Toronto) and transplant hepatology (Mayo Clinic). His academic training includes a Doctorate (PhD) and a Master's degree (MSCI) in clinical investigation from the National University of Mexico (UNAM).

Nadia Ovchinsky, MD, MBA, FAASLD is Chief of the Division of Pediatric Gastroenterology and Hepatology at Hassenfeld Children's Hospital at NYU Langone and Professor of Pediatrics at NYU Grossman School of Medicine. Dr. Ovchinsky received her combined Doctor of Medicine and Master of Business Administration in Healthcare Management degrees at Robert Wood Johnson Medical School and Rutgers University. Dr.

Dr. Davis is the Director of Liver Transplant at the Washington DC VA Medical Center. She is an Associate Professor of Medicine at Georgetown University. Her clinical interests include pharmacotherapy for metabolic liver disease, portal vein thrombosis and procedural bleeding in cirrhosis.

Chair of the Liver Unit of Hospital Clinic Barcelona, specialized in the management of portal hypertension and vascular liver diseases. Group Leader: Liver Disease & the Vascular System (LiVas)

Grace Wong is the Professor of The Chinese University of Hong Kong. She graduated from the Chinese University of Hong Kong in 2001 with honors and distinctions in Medicine. In 2010, she received the Doctoral Degree of Medicine of the Chinese University of Hong Kong.

Professor Yasuhiro Asahina received his medical degree from the Shiga University of Medical Science in 1988 and began his career with a clinical fellowship at the Tokyo Medical and Dental University Hospital. He subsequently pursued advanced research training at the University of Connecticut Health Center (USA) and the Tokyo Medical and Dental University, where he earned his Ph.D. in Medical Science in 1996.

Associate Professor Daniel Huang is a Senior Consultant at the National University Centre for Digestive Diseases and Chair of the Hepatobiliary Cancer Programme at the National University Cancer Institute (NCIS), Singapore. His research focuses on risk stratification of liver diseases, including MASH, hepatitis B, and hepatocellular carcinoma. Dr. Huang's work has informed international practice guidelines on hepatitis B, MASLD, and HCC, and he is contributing to local and international guideline development.